Exploring the Relationship between Psoriasis and Pregnancy: A Systematic Literature Review
DOI:
https://doi.org/10.5195/ijms.2023.1714Keywords:
Pregnancy, Psoriasis, HLA-Cw6, IL-23, TherapyAbstract
This systematic literature review examines the relationship between psoriasis and pregnancy to elucidate possible new routes of treatment. Findings from this review help reduce the gap in the literature on the topic as well as educate physicians and pregnant women with psoriasis on how psoriasis may present along the course of pregnancy and thereafter. Searches were primarily conducted in three databases: PubMed, Scopus, and Embase. Articles considered for inclusion in this literature review focused on the presentation of psoriasis during pregnancy. The literature sample obtained consisted of 14 peer-reviewed articles published from 2012-2022. As codes were identified, a master code list was developed. Second cycle coding involved categorizing of the data allowing for codes to combine and emerge as themes. Five themes were identified through categorical analysis: immunology, general sex hormones, estrogen, progesterone, and the HLA-Cw6 allele. Collectively, these findings elucidate the individual nature of psoriasis and identify progesterone as a possible non-teratogenic therapy. Primarily, the presence of the HLA-Cw6 allele in a woman’s genome along with the individual variation of estrogen receptors reinforces the researcher’s recommendation of genetic testing following a psoriasis diagnosis. This genetic testing may allow patients and physicians to best understand what to expect of psoriasis during pregnancy as well as help determine the most efficacious treatment course to follow for therapy.
Metrics
References
Armstrong, A.W., et al., Psoriasis Prevalence in Adults in the United States. JAMA Dermatol. 2021;157(8):940-6. DOI: https://doi.org/10.1001/jamadermatol.2021.2007
Lambert, J.L.W., et al., Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 1). J Eur Acad Dermatol Venereol. 2020;34(8):1654-65. DOI: https://doi.org/10.1111/jdv.16684
Simionescu, A.A., B.M. Danciu, and A.M.A. Stanescu, State-of-the-art review of pregnancy-related psoriasis. Medicina (Lithuania). 2021;57(8). DOI: https://doi.org/10.3390/medicina57080804
Mervic, L., Management of moderate to severe plaque psoriasis in pregnancy and lactation in the era of biologics. Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(2):27-31. DOI: https://doi.org/10.15570/actaapa.2014.7
Parisi, R., et al., National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. Bmj. 2020;369:m1590. DOI: https://doi.org/10.1136/bmj.m1590
Gratton, R., et al., Unraveling the Role of Sex Hormones on Keratinocyte Functions in Human Inflammatory Skin Diseases. Int J Mol Sci. 2022;23(6). DOI: https://doi.org/10.3390/ijms23063132
Hoffman, M.B., M. Farhangian, and S.R. Feldman, Psoriasis during pregnancy: characteristics and important management recommendations. Expert Rev Clin Immunol. 2015;11(6):709-20. DOI: https://doi.org/10.1586/1744666X.2015.1037742
Danesh, M. and J.E. Murase, The immunologic effects of estrogen on psoriasis: A comprehensive review. Int J Womens Dermatol. 2015;1(2):104-7. DOI: https://doi.org/10.1016/j.ijwd.2015.03.001
Vena, G.A., et al., Psoriasis in pregnancy: challenges and solutions. Psoriasis (Auckl). 2015;5:83-95. DOI: https://doi.org/10.2147/PTT.S82975
Boote, D.N.B., Penny, Scholars Before Researchers: On the Centrality of the Dissertation Literature Review in Research Preparation. 2005;34. DOI: https://doi.org/10.3102/0013189X034006003
Saldaña, J., The coding manual for qualitative researchers. 3rd ed. 2016: Sage.
Taurog, J.D., L.S. Gensler, and N. Haroon, Spondyloarthritis, in Harrison's Principles of Internal Medicine 21e, J. Loscalzo, et al., Editors. 2022, McGraw-Hill Education: New York, NY.
Sobolev, V., et al., Differential Expression of Estrogen-Responsive Genes in Women with Psoriasis. J Pers Med. 2021;11(9). DOI: https://doi.org/10.3390/jpm11090925
Tuğrul Ayanoğlu, B., et al., Diminished ovarian reserve in patients with psoriasis. Taiwan J Obstet Gynecol. 2018;57(2):227-30. DOI: https://doi.org/10.1016/j.tjog.2018.02.010
Lin, X. and T. Huang, Impact of pregnancy and oestrogen on psoriasis and potential therapeutic use of selective oestrogen receptor modulators for psoriasis. J Eur Acad Dermatol Venereol. 2016;30(7):1085-91. DOI: https://doi.org/10.1111/jdv.13661
Hellberg, S., et al., Progesterone Dampens Immune Responses in In Vitro Activated CD4(+) T Cells and Affects Genes Associated With Autoimmune Diseases That Improve During Pregnancy. Front Immunol. 2021;12:672168. DOI: https://doi.org/10.3389/fimmu.2021.672168
Adachi, A., et al., Estradiol suppresses psoriatic inflammation in mice by regulating neutrophil and macrophage functions. J Allergy Clin Immunol, 2022. DOI: https://doi.org/10.1016/j.jaci.2022.03.028
Cemil, B.C., et al., Sex hormones in male psoriasis patients and their correlation with the Psoriasis Area and Severity Index. J Dermatol. 2015;42(5):500-3. DOI: https://doi.org/10.1111/1346-8138.12803
Iwano, R., et al., Estrogen receptor α activation aggravates imiquimod-induced psoriasis-like dermatitis in mice by enhancing dendritic cell interleukin-23 secretion. J Appl Toxicol. 2020;40(10):1353-61. DOI: https://doi.org/10.1002/jat.3988
Chen, L. and T.F. Tsai, HLA-Cw6 and psoriasis. British Journal of Dermatology. 2018;178(4):854-62. DOI: https://doi.org/10.1111/bjd.16083
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Pratiksha Patra
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org